# An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density

> **NCT01101048** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 74 (actual)

## Conditions studied

- Osteopenia

## Interventions

- **DRUG:** Placebo
- **DRUG:** AMG 167

## Key facts

- **NCT ID:** NCT01101048
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101048, "An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01101048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*